
|Articles|December 1, 2017
- Pharmaceutical Executive-12-01-2017
- Volume 37
- Issue 12
Pharmaceutical Executive, December 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive December 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 8 years ago
Global Health: Fighting the Good Fightover 8 years ago
Global Health: Partnerships Hold the Keyalmost 9 years ago
First Foray into Digital Adherencealmost 9 years ago
Global Health: Messages of Hopealmost 9 years ago
A Year of Transformation for Science & Medicinealmost 9 years ago
Access and Reimbursement for Adoptive T-Cell Transfer Drugsalmost 9 years ago
Will Europe Turn a Corner in Personalized Medicine?almost 9 years ago
Fulfilling the Vision of Science: AstraZeneca's Ruud Dobberalmost 9 years ago
Country Report: CanadaAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Rebranding to'Novo'
2
Roundup: GSK Acquires Trispecific T Cell-Engager from Chimagen, Sanofi & Cheplapharm Form Strategic Partnership
3
Boards, AI, and 500 Years of Experience in Life Sciences: Takeaways from the 2026 Life Sciences Board Forum
4
Novartis Investors Share Concerns Over M&A Strategy: Report
5




